MetLife (XTER:MWZ) Gross Margin %


XTER:MWZ MetLife Inc XTER:MWZ
78 GF Score
Price €77.74
GF Value €77.66
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is MetLife Gross Margin %?

Gross Margin does not apply to banks and insurance companies.

XTER:MWZ
78GF Score
MetLife Inc XTER:MWZ
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MetLife (XTER:MWZ) Overvalued in 2026?

Based on GuruFocus' analysis, MetLife stock appears to be overvalued. The current stock price of €77.74 is trading 0.1% above its estimated GF Value™ of €77.66. GuruFocus considers MetLife to be Fairly Valued.

Key valuation signals for XTER:MWZ:

  • Gross Margin %:
  • GF Value™: €77.66 vs. price of €77.74 (0.1% above fair value)
  • GF Score™: 78/100 with 8 warning signs

No single metric tells the full story. See the XTER:MWZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MetLife Business Description

Address 200 Park Avenue, New York, NY, USA, 10166-0188
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
78GF Score

Get the complete analysis for XTER:MWZ

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€77.74
Price
€77.66
GF Value